AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Drugs typically used in later stages find a market in early stages as well.(breast cancer )(Brief Article)
2002 SEP 5 - (NewsRx.com & NewsRx.net) -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, announced that breast cancer drugs typically used in later stages of the disease will be used in early stages of the disease as well.
The report, entitled "Breast Cancer", also found that tamoxifen will see major competition from a new group of agents.
"Widely used tamoxifen has enjoyed market dominance in the treatment of early stage breast cancer," said Sarah Simnett, analyst, Decision Resources. "However, our findings indicate that a new group of agents are poised to take over tamoxifen's leading position. Third generation aromatase inhibitors are more effective and less ...
- Breast Cancer Drugs Typically Used In Later Stages Of The Disease Find A Market...
- Press release article from: PR Newswire July 9, 2002 700+ words
...Mass. -- Decision Resources, one of...today that breast cancer drugs typically...early stage breast cancer," said...analyst, Decision Resources. "However...states. Breast Cancer is an Onkos report. About Decision Resources Decision...
- Breast Cancer Drug Market to Exceed $6 Billion in 2012; Early-Stage Epothilones...
- Press release article from: PR Newswire November 17, 2003 700+ words
...PRNewswire/ -- Decision Resources, Inc...that the breast cancer (CaB) drug...analyst at Decision Resources. "The most...About Breast Cancer CaB is the...states. Breast Cancer is an Onkos study. About Decision Resources Decision...
- PRESS RELEASE: Decision Resources study on breast cancer finds that changes in...
- Newspaper article from: South China Morning Post January 22, 2001 700+ words
Decision Resources Inc has just published Breast Cancer, a new study that highlights key strategic issues and...anticipate that it will expand to $4.3 bn in 2009. Decision Resources Inc, Bay Colony Corporate Centre, 1100 Winter Street...
- Anti-Angiogenic Agents Hold Significant Potential for the Treatment of Cancer...
- Press release article from: PR Newswire July 24, 2002 700+ words
...WALTHAM, Mass. -- Decision Resources, one of the world...cell lung and breast cancer will benefit the...Curran, analyst, Decision Resources. "Because angiogenesis...Processes from Decision Resources Angiogenesis is...
- Genentech/Roche/Chugai's Avastin Will Garner More Than 20 Percent of the Total...
- Press release article from: PR Newswire October 21, 2008 700+ words
...with triple-negative breast cancer," said Niamh Murphy, Ph.D., analyst at Decision Resources. "As a result, there...treatment of triple-negative breast cancer." About Decision Resources Decision Resources (http...
- Breast cancer drug dev't hampered by lack of patients.
- Newspaper article from: Pharma Marketletter June 25, 2007 700+ words
...report entitled Breast Cancer from Decision Resources. Global drug behemoth...Phase III trails in breast cancer, and will be launched into the breast cancer market place in...Graham, director at Decision Resources. "We forecast...
- Breast cancer drug boom.
- Magazine article from: Chemistry and Industry July 3, 2006 700+ words
...Genentech/Roche's breast cancer drug Herceptin...market research firm Decision Resources. The increasing...drive growth in the breast cancer chemotherapy market. In addition, said Decision Resources, the launch of new...
- India's Breast Cancer Drug Market Will Almost Double by 2012.
- Press release article from: PR Newswire December 10, 2008 700+ words
...Report From Decision Resources WALTHAM...PRNewswire/ -- Decision Resources, one of the...the Indian breast cancer drug market...higher-income breast cancer patients...analyst at Decision Resources. EMERGING...
- Despite Oncologists' Willingness to Prescribe Avastin for Treatment of Breast...
- Press release article from: PR Newswire February 11, 2008 700+ words
...drug. An August 2007 survey by Decision Resources found that a very high rate...label to treat metastatic breast cancer. "In August of 2007, 79 percent...Fletcher-Louis., director at Decision Resources. "This prescribing behavior...
- If Herceptin is Approved in Combination With Other Emerging Therapies it Will...
- Press release article from: PR Newswire February 11, 2009 700+ words
...Positive Breast Cancer: Oncologists...will become Decision Resources' proprietary...positive breast cancer by 2017. This...analyst at Decision Resources. About the...Positive Breast Cancer: Oncologists...
Source: HighBeam Research, Drugs typically used in later stages find a market in early stages as...